| Product Code: ETC9943000 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Dry Age Macular Degeneration Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Dry Age Macular Degeneration Market - Industry Life Cycle |
3.4 United Kingdom (UK) Dry Age Macular Degeneration Market - Porter's Five Forces |
3.5 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.6 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume Share, By Diagnosis and Treatment, 2021 & 2031F |
3.8 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United Kingdom (UK) Dry Age Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in the aging population of the UK |
4.2.2 Technological advancements in diagnostic tools and treatment options for dry age-related macular degeneration |
4.2.3 Rising awareness about eye health and the importance of early detection and treatment of AMD |
4.3 Market Restraints |
4.3.1 High treatment costs associated with advanced treatments for dry age-related macular degeneration |
4.3.2 Limited access to specialized eye care professionals in certain regions of the UK |
4.3.3 Regulatory challenges and stringent approval processes for new AMD treatment options |
5 United Kingdom (UK) Dry Age Macular Degeneration Market Trends |
6 United Kingdom (UK) Dry Age Macular Degeneration Market, By Types |
6.1 United Kingdom (UK) Dry Age Macular Degeneration Market, By Stages |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Stages, 2021- 2031F |
6.1.3 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Early Age-Related Macular Degeneration, 2021- 2031F |
6.1.4 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Intermediate Age-Related Macular Degeneration, 2021- 2031F |
6.1.5 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Late Age-Related Macular Degeneration, 2021- 2031F |
6.2 United Kingdom (UK) Dry Age Macular Degeneration Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2.3 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.2.4 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Above 40 Years, 2021- 2031F |
6.3 United Kingdom (UK) Dry Age Macular Degeneration Market, By Diagnosis and Treatment |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Treatment, 2021- 2031F |
6.3.3 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4 United Kingdom (UK) Dry Age Macular Degeneration Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Injectables, 2021- 2031F |
6.5 United Kingdom (UK) Dry Age Macular Degeneration Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.3 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.5.4 United Kingdom (UK) Dry Age Macular Degeneration Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
7 United Kingdom (UK) Dry Age Macular Degeneration Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Dry Age Macular Degeneration Market Export to Major Countries |
7.2 United Kingdom (UK) Dry Age Macular Degeneration Market Imports from Major Countries |
8 United Kingdom (UK) Dry Age Macular Degeneration Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for dry age-related macular degeneration patients in the UK |
8.2 Percentage of AMD patients in the UK receiving regular eye screenings for early detection |
8.3 Adoption rate of innovative diagnostic tools and treatment options for dry age-related macular degeneration in the UK |
9 United Kingdom (UK) Dry Age Macular Degeneration Market - Opportunity Assessment |
9.1 United Kingdom (UK) Dry Age Macular Degeneration Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.2 United Kingdom (UK) Dry Age Macular Degeneration Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 United Kingdom (UK) Dry Age Macular Degeneration Market Opportunity Assessment, By Diagnosis and Treatment, 2021 & 2031F |
9.4 United Kingdom (UK) Dry Age Macular Degeneration Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Dry Age Macular Degeneration Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United Kingdom (UK) Dry Age Macular Degeneration Market - Competitive Landscape |
10.1 United Kingdom (UK) Dry Age Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Dry Age Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here